HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery

In recent years, cell therapy technologies have resulted in impressive results in hematologic malignancies. Treatment of solid tumors with chimeric antigen receptor T-cells (CAR-T) has been less successful. Solid tumors present challenges not encountered with hematologic cancers, including high intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, Steven C, Moody, Ashley E, Guha, Prajna, Hardaway, John C, Prince, Ethan, LaPorte, Jason, Stancu, Mirela, Slansky, Jill E, Jordan, Kimberly R, Schulick, Richard D, Knight, Robert, Saied, Abdul, Armenio, Vincent, Junghans, Richard P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449487/
https://www.ncbi.nlm.nih.gov/pubmed/32843493
http://dx.doi.org/10.1136/jitc-2020-001097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449487/
https://www.ncbi.nlm.nih.gov/pubmed/32843493
http://dx.doi.org/10.1136/jitc-2020-001097

Ejemplares similares